August 1, 2018 – Charleston, SC, USA – RichSource Stem Cells, Inc. (RichSource), a leader in the business development and distribution of human tissue allograft combination products and membranes, announced today its own brand product line: RICHGEN. With the introduction of this breakthrough line, the industry is no longer limited to single material post-birth, multipotent cellular products. Available throughout the U.S., the RICHGEN product line is backed by an experienced nationwide team of RichSource Area Vice Presidents who can educate, train and provide support to physician practices and networks. Additionally, RichSource’s simplified and more effective treatment protocols helps to optimize practices and patient results. [Read more…]
Fresenius Medical Care achieves preclinical milestone in its regenerative medicine program for chronic kidney disease
July 30, 2018 – Fresenius Medical Care, the world’s largest provider of dialysis products and services, announced today that its subsidiary Unicyte AG has achieved a key preclinical milestone in its regenerative medicine program for chronic kidney disease. The company was able to confirm a disease modifying potential for its proprietary nano-Extracellular Vesicles (“nEVs” are stem cell-derived particles that support communication between cells) in a second preclinical model of chronic kidney disease. [Read more…]
University of Miami Researchers Present the Latest at the American Association of Stem Cell Physicians (AAOSCP) Annual Summit
August 16, 2018, Miami, FL — The American Association of Stem Cell Physicians (AAOSCP) concluded a highly successful annual summit held from August 10 – 12, 2018, in Miami, FL. Attended by a global audience, the event featured researchers from the University of Miami who presented the latest research on stem cell applications.
The spokesperson for American Association of Stem Cell Physicians, A.J. Farshchian, MD, stated: “The American Association of Stem Cell Physicians is solely committed to create an educational platform based on solid foundational research. Our goal is to enhance the quality of medical practice and the continued education of physicians. [Read more…]
Irvine Scientific Introduces Chemically-Defined Natural Killer Cell Expansion Medium for Immunotherapy & Translational Research Applications
The first chemically-defined, animal component-free cell culture medium for natural killer (NK) cells
July 2018, Santa Ana, Calif. — Irvine Scientific, an industry leader in the development and manufacture of cell culture media, announced the introduction of PRIME-XV® NK Cell CDM— the first commercially available chemically-defined (CDM), animal component-free (ACF) medium for the ex vivo expansion of NK cells. The advanced medium delivers natural killer (NK) cell expansion while preserving NK cell potency and functionality. [Read more…]
Cell Symposia to Host “Translation of Stem Cells to the Clinic” | Dec 2-4 in Los Angeles
Cell Symposia is honored to be hosting this year’s annual conference, “Translation of Stem Cells to the Clinic: Challenges and Opportunities.” This year’s event will be hosted at Cedars Sinai in Los Angeles, CA from December 2-4th, 2018.
The goal of the event is to bring clinicians, basic stem cell biologists, and cell manufacturing and pharmaceutical stakeholders together to discuss the challenges and opportunities for clinical translation of stem cell research and to help synergize efforts taking place in a variety of systems at diverse stages in the process. [Read more…]
- « Previous Page
- 1
- …
- 177
- 178
- 179
- 180
- 181
- …
- 313
- Next Page »